日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparative analysis of ctDNA monitoring strategies in advanced NSCLC with MET exon 14 skipping mutations treated with ensartinib

对接受恩沙替尼治疗的伴有MET外显子14跳跃突变的晚期非小细胞肺癌患者ctDNA监测策略进行比较分析

Zhou, Mo; Zhu, Yin; Sun, Xuqi; Han, Ying; Jin, Rui; Tian, Panwen; Zhao, Jun; Jin, Yang; Guo, Zhiyuan; Zhang, Yongchang; Meng, Yiran; Liu, Fei; Li, Wen; Le, Xiuning; Shen, Haifeng; Xia, Yang

Nanodelivery of Traditional Chinese Medicine Monomers: An Emerging Strategy to Reprogram the Immunosuppressive Tumor Microenvironment

中药单体纳米递送:重塑免疫抑制性肿瘤微环境的新兴策略

Zhong, Lin; Xing, Minyan; Yu, Jiaze; Sun, Xuqi; Dai, Xiaomeng; Bao, Xuanwen; Huang, Chenping; Han, Jing; Li, Jianping; Zhao, Peng

Spatially resolved C1QC(+) macrophage-CD4(+) T cell niche in colorectal cancer microenvironment: implications for immunotherapy response.

结直肠癌微环境中空间分辨的 C1QC(+) 巨噬细胞-CD4(+) T 细胞微环境:对免疫治疗反应的影响

Zhang Hangyu, Hong Libing, Dong Zhen, Xin Shan, Lin Bo, Cheng Jinlin, Tian Weihong, Li Bin, Wang Jing, Liu Xiaoyan, Liu Chuan, Jin Yuzhi, Feng Yanzhi, Su Ge, Sun Xuqi, Liu Qiqi, Dai Xiaomeng, Gao Yang, Tong Zhou, Liu Lulu, Zhu Xudong, Zheng Yi, Zhao Peng, Guo Tiannan, Fang Weijia, Bao Xuanwen

In-depth plasma proteomics reveals the dynamic changes and prognostic biomarkers for chimeric antigen receptor-glypican-3 T-cell therapy in patients with hepatocellular carcinoma

深入的血浆蛋白质组学分析揭示了嵌合抗原受体-糖蛋白聚糖-3 T细胞疗法治疗肝细胞癌患者的动态变化和预后生物标志物

Zhu, Xudong; Yang, Ziliang; Li, Bin; Tong, Zhou; Yan, Junyi; Song, Lei; Bao, Xuanwen; Hong, Libin; Jin, Yuzhi; Meng, Lina; Liu, Lulu; Dai, Xiaomeng; Zhao, Tianyi; Wen, Shiting; Qin, Haokang; Jin, Sujie; Zhao, Peng; Zheng, Yi; Fang, Weijia; Li, Zonghai; Sun, Xuqi; Liang, Tingbo

A Pathologically Friendly Strategy for Determining the Organ-specific Spatial Tumor Microenvironment Topology in Lung Adenocarcinoma Through the Integration of snRandom-seq and Imaging Mass Cytometry

一种通过整合snRandom-seq和成像质谱流式细胞术来确定肺腺癌器官特异性空间肿瘤微环境拓扑结构的病理友好策略

Sun, Xuqi; Teng, Xiao; Liu, Chuan; Tian, Weihong; Cheng, Jinlin; Hao, Shuqiang; Jin, Yuzhi; Hong, Libing; Zheng, Yongqiang; Dai, Xiaomeng; Wu, Linying; Liu, Lulu; Teng, Xiaodong; Shi, Yi; Zhao, Peng; Fang, Weijia; Shi, Yu; Bao, Xuanwen

Impact of treatment interval between neoadjuvant immunochemotherapy and surgery in lung squamous cell carcinoma

新辅助免疫化疗与手术治疗间隔时间对肺鳞状细胞癌的影响

Gu, Chen; Teng, Xiao; Sun, Xuqi; Liu, Jiacong; Zhu, Ziyue; Zhang, Lichen; Wu, Zhigang; Zou, Rui; Pang, Jinghua; Lyu, Xiayi

Optimal therapeutic strategy for non-small cell lung cancer with thoracic extrathoracic metastasis: a study based on SEER database

胸腔外转移性非小细胞肺癌的最佳治疗策略:基于SEER数据库的研究

He, Zhehao; Sun, Xuqi; Xu, Jinming; Wang, Luming; Cheng, Jun; Lv, Wang; Hu, Jian

Resveratrol reduces ROS-induced ferroptosis by activating SIRT3 and compensating the GSH/GPX4 pathway

白藜芦醇通过激活 SIRT3 和补偿 GSH/GPX4 通路减少 ROS 诱导的铁死亡

Xingjie Wang #, Tianli Shen #, Jie Lian, Kai Deng, Chao Qu, Enmeng Li, Gan Li, Yiwei Ren, Zijun Wang, Zhengdong Jiang, Xuejun Sun, Xuqi Li

Development and Validation of Novel Models Including Tumor Micronecrosis for Predicting the Postoperative Survival of Patients with Hepatocellular Carcinoma

开发和验证包含肿瘤微坏死在内的新型模型,用于预测肝细胞癌患者术后生存率

Sun, Xuqi; Wang, Yangyang; Ge, Hongbin; Chen, Cao; Han, Xu; Sun, Ke; Wang, Meng; Wei, Xiaobao; Ye, Mao; Zhang, Qi; Liang, Tingbo

Tumor micronecrosis predicts poor prognosis of patients with hepatocellular carcinoma after liver transplantation

肿瘤微坏死预示着肝细胞癌患者肝移植后预后不良。

Wang, Yangyang; Zhang, Wei; Ge, Hongbin; Han, Xu; Wu, Jiangchao; Sun, Xuqi; Sun, Ke; Cao, Wanyue; Huang, Chao; Li, Jingsong; Zhang, Qi; Liang, Tingbo